Levemir-Body Composition and Energy Metabolism

PHASE4CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

April 30, 2014

Conditions
Type 2 Diabetes
Interventions
DRUG

Detemir or Glargine

Initial dose of 10 units of insulin at bedtime. The insulin dose will be increase by 1 unit per day until fasting plasma glucose (FPG) levels are 5.0 mmol/L.

Trial Locations (1)

H2W 1R7

Institut de Recherches Cliniques de Montréal, Montreal

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novo Nordisk A/S

INDUSTRY

collaborator

McMaster University

OTHER

lead

Institut de Recherches Cliniques de Montreal

OTHER